Мозг. От хорошего к превосходному - Дэниэл Дж. Амен

CoQ10

Baggio, E., et al. «Italian Multicenter Study on the Safety and Efficacy of Coenzyme Q10 as Adjunctive Therapy in Heart Failure», Molecular Aspects of Medicine 15 (Suppl.) (1994): 287–94.

Chopra, R. K., et al. «Relative Bioavailability of Coenzyme Q10 Formulations in Human Subjects», International Journal for Vitamin and Nutrition Research 68 (1998): 109–13.

Crane, F. L, I. L. Sun, and E. E. Sun, «The Essential Functions of Coenzyme Q», Clinical Investigator 71 (Suppl.) (1993): S55–59.

Folkers, K., et al. «Lovastatin Decreases Coenzyme Q Levels in Humans», Proceedings of the National Academy of Science 87 (1990): 8931–34.

Hanaki, Y., et al. «Coenzyme Q10 and Coronary Artery Disease», Clinical Investigator7. (Suppl.) (1993): SI 12–15.

Matthews, R. Т., et al. «Coenzyme Q10 Administration Increases Mitochondrial Concentrations and Exerts Neuroprotective Effects», Proceedings of the National Academy of Science 95(1998): 8892–97.

Shults, C. W, et al. «Pilot Trial of High Dosages of Coenzyme Q10 in Patients with Parkinson’s Disease», Experimental Neurology 188, no. 2 (August 2004): 491–94.

Spigset, O., «Reduced Effect of Warfarin Caused by Ubidecarenone», Lancet 344 (1994): 1372–73.

Рыбий жир

Adler, A. J., and B. J. Holub, «Effect of Garlic and Fish-Oil Supplementation on Serum Lipid and Lipoprotein Concentrations in Hypercholesterolemic Men», American Journal of Clinical Nutrition 65 (1997): 445–50.

Appel, L. J., et al. «Does Supplementation of Diet with ‘Fish Oil’ Reduce Blood Pressure? A Meta-Analysis of Controlled Clinical Trials», Archives of Internal Medicine 153 (1993): 1429–38.

Ariza-Ariza, R., M. Mestanza-Peralta, and М. H. Cardiel, «Omega-3 Fatty Acid in Rheumatoid Arthritis: An Overview», Seminars in Arthritis and Rheumatism 27 (1998): 366–70.

Belluzi, A., et al. «Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn’s Disease», New England Journal of Medicine 334 (1996): 1557–60.

GISSI-Prevenzione Investigators, «Dietary Supplementation with N-3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial», Lancet 354 (1999): 447–55.

Grimsgaard, S., et al. «Highly Purified Eicosapentaenoic Acid and Docosa-hexaenoic Acids in Humans Have Similar Triacylglycerol-Lowering Effects but Divergent Effects on Serum Fatty Acids», American Journal of Clinical Nutrition 66 (1997): 649–59.

Saldeen, P., and T. Saldeen, «Women and Omega-3 Fatty Acids», Obstetrical and Gynecological Survey 59, no. 10 (October 2004): 722–30, 745–46.

Stoll, A. L., et al. «Omega-3 Fatty Acids in Bipolar Disorder», Archives of General Psychiatry 56 (1999): 407–12.

Гинкго билоба

Blume, J., M. Kieser, and U. Holscher, «[Placebo-Controlled Double-Blind Study of the Effectiveness of Ginkgo Biloba Special Extract EGb 761 in Trained Patients with Intermittent Claudication]», Vasa 25, no. 3 (1996): 265–74.

[Ginkgo-Special-Extract EGb 761 in Peripheral Arterial Occlusive Diseases Stage lib According to Fontaine], Fortschritte JerMedizin 116, nos. 35–36 (1997): 36–37.

Blumenthal, M., A. Goldberg, J. Brinckmann, eds; Tyler, V. E., «Herbal Medicine: Expanded Commission E Monographs» (American Botanical Council, 2000).

Blumenthal, M., et al. eds, Klein, S.; R. S. Rister, trans, V. E. Tyler, «The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines» (American Botanical Council, 1998).

Haase, J., P. Halama, and R. Horr, «Effectiveness of Brief Infusions with Ginkgo Biloba Special Extract EGb 761 in Dementia of the Vascular and Alzheimer Type», Zeitschrift fur Gerontologic und Geriatric 29, no. 4 (1996): 302–09.

Hofferberth, B., «The Effect of Ginkgo Biloba Extract on Neurophysiological and Psychometric Measurement Results in Patients with Psychotic Organic Brain Syndrome. A Double-Blind Study Against Placebo», Arzneimittelforschung 39, no. 8 (1989): 918–22.

Kanowski, S., et al. «Proof of the Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type of Multi-Infarct Dementia», Phytomedicine 4 (1997): 3–13.

Kennedy, D. О., A. B. Scholey, and K. A. Wesnes, «The Dose-Dependent Cognitive Effects of Acute Administration of Ginkgo Biloba to Healthy Young Volunteers», Psychopharmacology 151, no. 4 (2000): 416–23.

Le Bars, P. L. et al. «A Placebo-Controlled, Double-Blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia. North American EGb Study Group», Journal of the American Medical Association 278, no. 16 (1997): 1327–32.

Le Bars, P. L., M. Kieser, and K. Z. Itil, «A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo Biloba Extract EGb 761 in Dementia», Dementia and Geriatric Cognitive Disorders 11, no. 4 (2000): 230–37.

Mix, J. A., and W. D. Crews, Jr., «An Examination of the Efficacy of Ginkgo Biloba Extract EGb 761 on the Neuropsychologic Functioning of Cognitively Intact Older Adults», Journal of Alternative and Complementary Medicine 6, no. 3 (1999): 219–29.

Oken, В. S., D. М. Storzbach, and J. A. Kaye, «The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease», Archives of Neurology 55, no. 11 (1997): 1409–15.

Rigney, U., S. Kimber, and I. Hindmarch, «The Effects of Acute Doses of Standardized Ginkgo Biloba Extract on Memory and Psychomotor Performance in Volunteers», Phytotherapy Research 13, no. 5 (1999): 408–15.

Santos, R. F., et al. «Cognitive Performance, SPECT, and Blood Viscosity in Elderly Non-Demented People Using Ginkgo Biloba», Pharmacopsychiatry 36, no. 4 (July 2003): 127–33.

Stough, C., et al. «Neuropsychological Changes After 30-Day Ginkgo Biloba Administration in Healthy Participants», International Journal of Neuropsychopharmacology 4, no. 2 (2001): 131–34.

Wesnes, K. A., et al. «The Memory Enhancing Effects of a Ginkgo Biloba/Panax Ginseng Combination in Healthy Middle-aged Volunteers», Psychopharmacology 152, no. 4 (2000): 353–61.

Yoshikawa, Т., Y. Naito, and M. Kondo, «Ginkgo Biloba Leaf Extract: Review of Biological Actions and Clinical Applications», Antioxidants and Redox Signaling 1, no. 4 (1999): 469–80.

Фосфатидилсерин

Amaducc, L. and SMID Group, «Phosphatidylserine in the Treatment of Alzheimer’s Disease. Results of a Multicenter Study», Psychopharmacology Bulletin 24 (1988): 130–34.